Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lucas Capital Management Reveals Top Picks for Q3; Apple Inc. (AAPL) and Johnson & Johnson (JNJ) Among Them

Page 1 of 3

Lucas Capital Management LLC is a New Jersey-based investment firm founded by George B. Lucas Jr. and his son, Russell Lucas, in 1996. The firm currently manages over $700 million across four hedge funds, three private equity funds and its legacy private wealth management business. While Lucas Capital Management’s hedge and private equity funds are focused on investing in oil, gas and the broader energy spectrum, the firm’s private wealth management business seeks to construct a diversified portfolio of well-established companies. The investment firm seeks to invest in companies boasting strong growth and fundaments that trade at a reasonable price-to-earnings ratios.

Lucas Capital Management recently submitted its 13F filing for the second quarter of 2016 with the U.S. Securities and Exchange Commission, revealing an equity portfolio worth $141.28 million. This compares with the $136.96 million-portfolio recorded at the end of the March quarter. Expectedly, approximately 44% of the asset manager’s portfolio comprises energy-related equity investments, while healthcare-related investments account for 14% of that portfolio. Without further ado, let’s discuss Lucas Capital Management’s five largest equity holdings as of the end of the second quarter.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see more details here).

investment, team, business, boardroom, results, data, annual, dark, graphs, review, cooperation, pen, report, focus, briefing, human, strategic, documents, statistical,

Pressmaster/Shutterstock.com

#5. B&G Foods Inc. (NYSE:BGS)

– Shares owned by Lucas Capital Management as of June 30: 112,559

– Value of Lucas Capital Management’s holding as of June 30: $5.43 Million

Lucas Capital Management cut its stake in B&G Foods Inc. (NYSE:BGS) by 14% during the second quarter of 2016 to 112,559 shares. The reduced stake was valued at $5.43 million on June 30 and made up 3.8% of the investment firm’s entire portfolio. The shelf-stable and frozen foods company, whose acquisition-focused growth strategy involves buying unloved brands on sale, has seen its market value jump by 46% since the beginning of 2016. In November 2015, the company completed the acquisition of the Green Giant and Le Sueur brands from General Mills Inc. (NYSE:GIS) for $765 million in cash, an acquisition anticipated to add an estimated $550 million in sales annually. B&G Foods reported second-quarter net sales of $306.38 million, up a whopping 58.2% year-over-year. Net sales of Green Giant contributed $107.2 million to the company’s top line for the quarter. Meanwhile, base business net sales for the quarter decreased by 1.3% year-on-year. Ken Fisher’s Fisher Asset Management owns 79,901 shares of B&G Foods Inc. (NYSE:BGS) as of June 30.

Follow B&g Foods Inc. (NYSE:BGS)
Trade (NYSE:BGS) Now!

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!